We examined lymphocyte subpopulations in the peripheral blood and serum concentrations of immunoglobulin (Ig) in 8 patients with tsutsugamushi disease. In 7 of the 8 cases, there was a 4-fold or greater increase in IgG and IgM antibody titers between the initial and convalescent serum specimens. In one case, there was no increase, but IgM antibodies were detected with diagnostically significant antibody titers. The percentages of CD8-and CD2-positive lymphocytes measured before treatment were found to be significantly higher than during the recovery stage of patients with tsutsugamushi disease. The CD4/CD8 ratio in the peripheral blood calculated before treatment was significantly lower than that during the recovery stage. Serum concentrations of IgG and IgM in patients during the recovery stage were significantly higher than pretreatment levels, respectively.
Introduction
Tsutsugamushi is an infectious disease known to be caused by Rickettsia (R.) tsutsugamushi, by which its cellular immunity is impaired during infectionl>2>. There are few reports, however, concerning lymphocyte subpopulations in the peripheral blood of patients with tsutsugamushi disease3).
In this report, we recognized that the lymphocyte subpopulations of patients with tsutsugamushi disease changed with the clinical course of this disease.
Materials and Methods

Materials
Eight subjects (6 males, 2 females) with tsutsugamushi disease were examined between November, 1985 and March, 1987. The age of the patients ranged from 20 to 79 years. Fresh heparinized peripheral venous blood samples were obtained from the patients with tsutsugamushi disease. Leukocytes were counted, and May-Grunwald-Giemsa staining of peripheral blood samples was performed for analysis of leukocytes. The remaining venous blood was used for serodiagnosis of R. tsutsugamushi and analysis of lymphocyte subpopulations.
Detection of R. tsutsugamuschi antibodies R. tsutsugamushi-specific antibody was determined by the indirect immunofluorescence method4)5) Lymphocyte subpopulations in peripheral blood Lymphocyte subpopulations were determined by monoclonal antibodies using a flow cytometric whole blood method6). The monoclonal antibodies used for the study were CD3, CD4, CD8, CD2 (Ortho), CD20, (Coulter) and Leu7 (Becton Dickinson). For direct immunofluorescence staining, we added 2-5 ,uL of whole blood and the same volume of calcium-and magnesium-free phosphate-buffered saline. After 30 min of incubation on ice, we added 2 mL of lysing solution (0.85% NH4C1) to the sample for 10-15 min at room temperature, then the sample was filtrated by Nilon Mesh with 45 pm pores (Ieda Laboratories). The sample was subsequently analysed with an Epics V Laser Flow Cytometry System (Coulter).
Detection of serum immunoglobulin concentration Serum concentrations of immunoglobulin were examined before treatment and recovery stage using a laser nephelometer7181.
Statistical analysis The significance of results was calculated with paired t-test.
Results
Antibodies to R. tsutsugamushi Table 1 shows the results of and-R. tsutsugamushi antibody titration for 8 patients by indirect immunofluorescence. In 7 of 8 cases, there was a 4-fold or greater increase in IgG and IgM antibody titers between the initial and convalescent serum specimens. In one case (T.S.), there was no increase, but IgM antibodies were detected with diagnostically significant antibody titers. Lymphocyte subpopulations The percentage and absolute number of lymphocytes in peripheral blood prior to treatment were relatively lower than those during the recovery stage. The lymphocyte subpopulations in peripheral blood of patients with tsutsugamushi disease are summarized in Table 2 . The percentages of CD8-and CD2-positive lymphocytes measured before treatment were found to be significantly higher than during the recovery stage, whereas the percentage of CD20-positive lymphocytes before treatment was significantly lower than at the recovery stage (Fig. 1, 2) . The CD4/CD8 ratio calculated before treatment was recognized to be significantly lower than compared with the result for the recovery stage (Fig. 3) .
Serum immunoglobulin levels Serum concentrations of IgG and IgM in patients at the recovery stage were found to be significantly higher than for individual patients before treatment, respectively, while the IgA level did not show a significant statistical difference between the recovery and pretreatment stages (Fig. 4) .
Discussion
It has been reported that the change in lymphocyte subpopulations of the peripheral blood in patients is associated with various infectious diseases, such as viral infections9)10) and tuberculosis11). In patients with tsutsugamushi disease, lymphocytes in the peripheral blood often revealed a decrease in the acute stage of this disease12); however, the alteration of lymphocyte number and lymphocyte subpopulations in patients with this disease is not yet completely understood. Moreover, the infectivity of R. tsutsugamushi to lymphocytes has not been clarified, although infectivity to the peritoneal exudate cells has been wellknown13). In this study, we recognized an alteration of the number of lymphocytes and lymphocyte subpopulations occurring in patients with tsutsugamushi disease. Especially, the percentages of CD8-and CD2-positive lymphocytes measured before treatment produced results which were significantly higher than those during the recovery stage. Moreover, the CD4/CD8 ratio in the peripheral blood calculated before treatment was significantly lower than that during the recovery stage. In patients with immune deficiency syndrome (AIDS), it has been reported that human immunodeficiency virus (HIV) has selective tropism for CD4 antigen14) and the CD4-positive lymphocytes infected with HIV are easily destroyed14). Furthermore, Giorgi et al.15) and Vuillier et al.16) reported that both 4B4-positive and 2H4-positive lymphocytes among CD4-positive lymphocytes were destroyed to an almost similar extent. From our data, although we have not obtained a direct evidence about the alteration of lymphcyte subpopulations in the peripheral blood of patients with tsutsugamushi disease, it is suggested that cells infected with R. tsutsugamushi may destroy mainly the CD4-positive lymphocytes, or they may be destroyed due to R. tsutsugamushi infeciton. It is known that the level of y-globulin in the sera of patients with tsutsugamushi disease is elevated during the recovery stage of this disease. In our study, we recognized significantly elevated IgG and IgM levels, and titer of specific antibody to R. tsutsugamushi in the sera of patients with tsutsugamushi disease at recovery stage. Jerrells et al. reported that mature T-lymphocytes were necessary for the production of specific antibody to R. tsutsugamushi17). Especially, CD4-positive lymphocytes among mature T-lymphocytes have helper function for B cell maturation and immunoglobulin production") . Recovery of the CD4/CD8 ratio and increase of CD20-positive lymphocytes in the peripheral blood during the recovery stage of patients with tsutsugamushi disease might be responsible for the elevated IgG and IgM levels , and titer of specific antibody to R. tsutsugamushi, in our study.
Although we could not clarify the mechanism of alteration of lymphocyte subpopulations in the peripheral blood of patients with tsutsugamushi disease, lymphocyte subpopulations changes with the clinical course of this disease, i.e. before treatment and during recovery . These results might be related to the immune stage of patients with tsutsugamushi disease.
